Baseimmune

Baseimmune is a discovery-stage biotechnology company that is revolutionizing vaccine design through advanced computational antigen design. Founded by a team of vaccine and software developers with roots at the Jenner Institute University of Oxford, Baseimmune aims to create cross-protective and mutation-proof vaccines by harnessing the power of data science, machine learning, and computational biology. The company uses its proprietary platform to predict how pathogens will evolve and design antigens that are effective against both current and future variants.

Baseimmune has a strong track record of success, having designed over 15 vaccines, with two currently in human clinical trials. The company is backed by leading investors from Europe and the US, including MSD Global Health Innovation Fund, Hoxton Ventures, Creator Fund, and Maki.vc. Baseimmune is committed to developing life-saving vaccines and has a diverse team of biologists, computer engineers, bioinformaticians, immunologists, and visionaries who are passionate about pushing the boundaries of what science can achieve.

Baseimmune offers a flexible working environment, allowing employees to work fully remotely or in a hybrid model, combining both office and remote work. This flexibility provides employees with the freedom to work in a way that best suits their needs and preferences, fostering a work-life balance.

Baseimmune offers a comprehensive benefits package to its employees, including a competitive starting salary, private medical health insurance, opportunities for career growth and professional development, 26 days of holiday leave plus bank holidays, enhanced sick pay, a pension plan, and the opportunity for fully remote or hybrid working styles.

Baseimmune is a biotechnology company focused on developing mutation-proof vaccines against infectious diseases. They utilize a proprietary AI platform that combines scientific expertise and genomic, proteomic, epidemiological, and immunological data to create novel, synthetic antigens that target pathogen evolution, leading to highly effective and cross-protective vaccines. Their mission is to combat emerging and complex pathogens that have been difficult to address with traditional vaccine approaches, ultimately creating a world without pandemics.

Baseimmune fosters a collaborative and multidisciplinary work environment where innovation, excellence, and results are highly valued. The company encourages direct communication, teamwork, and continuous learning, promoting a culture of transparency and accountability. They are passionate about achieving impactful results and believe in moving at a rapid pace to stay ahead of the curve in vaccine development.

Baseimmune is committed to building a collaborative and multidisciplinary environment where ideas can flow freely. They strive to assemble an exceptional and diverse team of biologists, computer engineers, bioinformaticians, immunologists, and visionaries to push the boundaries of what science can achieve. Their core values of innovation, excellence, focus on results and delivery, collaboration, learning, integrity, being direct, and being all in drive their commitment to a diverse and inclusive workplace. They are backed by leading investors from Europe and the US, such as MSD Global Health Innovation Fund, Hoxton Ventures, Creator Fund, Maki VC, Rockmount Capital, Cherry VC, Beast Ventures, Tiny VC, Voyagers, The Francis Crick Institute and Angels.